Cargando…
Anti-addiction vaccines
Despite intensive efforts to eradicate it, addiction to both legal and illicit drugs continues to be a major worldwide medical and social problem. Anti-addiction vaccines can produce the antibodies to block the effects of these drugs on the brain, and have great potential to ameliorate the morbidity...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculty of 1000 Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186043/ https://www.ncbi.nlm.nih.gov/pubmed/22003367 http://dx.doi.org/10.3410/M3-20 |
_version_ | 1782213288436695040 |
---|---|
author | Shen, Xiaoyun Orson, Frank M. Kosten, Thomas R. |
author_facet | Shen, Xiaoyun Orson, Frank M. Kosten, Thomas R. |
author_sort | Shen, Xiaoyun |
collection | PubMed |
description | Despite intensive efforts to eradicate it, addiction to both legal and illicit drugs continues to be a major worldwide medical and social problem. Anti-addiction vaccines can produce the antibodies to block the effects of these drugs on the brain, and have great potential to ameliorate the morbidity and mortality associated with illicit drug intoxications. This review provides a current overview of anti-addiction vaccines that are under clinical trial and pre-clinical research evaluation. It also outlines the development challenges, ethical concerns, and likely future intervention for anti-addiction vaccines. |
format | Online Article Text |
id | pubmed-3186043 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Faculty of 1000 Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-31860432011-10-14 Anti-addiction vaccines Shen, Xiaoyun Orson, Frank M. Kosten, Thomas R. F1000 Med Rep Review Article Despite intensive efforts to eradicate it, addiction to both legal and illicit drugs continues to be a major worldwide medical and social problem. Anti-addiction vaccines can produce the antibodies to block the effects of these drugs on the brain, and have great potential to ameliorate the morbidity and mortality associated with illicit drug intoxications. This review provides a current overview of anti-addiction vaccines that are under clinical trial and pre-clinical research evaluation. It also outlines the development challenges, ethical concerns, and likely future intervention for anti-addiction vaccines. Faculty of 1000 Ltd 2011-10-03 /pmc/articles/PMC3186043/ /pubmed/22003367 http://dx.doi.org/10.3410/M3-20 Text en © 2011 Faculty of 1000 Ltd http://creativecommons.org/licenses/by-nc/3.0/legalcode This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. You may not use this work for commercial purposes |
spellingShingle | Review Article Shen, Xiaoyun Orson, Frank M. Kosten, Thomas R. Anti-addiction vaccines |
title | Anti-addiction vaccines |
title_full | Anti-addiction vaccines |
title_fullStr | Anti-addiction vaccines |
title_full_unstemmed | Anti-addiction vaccines |
title_short | Anti-addiction vaccines |
title_sort | anti-addiction vaccines |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186043/ https://www.ncbi.nlm.nih.gov/pubmed/22003367 http://dx.doi.org/10.3410/M3-20 |
work_keys_str_mv | AT shenxiaoyun antiaddictionvaccines AT orsonfrankm antiaddictionvaccines AT kostenthomasr antiaddictionvaccines |